Cribriform-positive prostate cancer outcomes needs to be further risk stratified to identify patients at high risk for metastasis.
A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Health and Me on MSN
Urological cancers rising in India: How timely screening could save lives
With a growing number of patients reaching hospitals at an advanced stage, doctors stress that timely urological screening is ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
BALTIMORE, April 16, 2026 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA), in partnership with the American Society for Radiation Oncology (ASTRO), released the 2026 amendment to ...
Learn about prostate cancer risks, warning signs, and the importance of PSA testing for early detection and treatment.
Drugs used for prostate cancer may not increase bleeding or clotting risks when used with blood thinners, thus providing ...
Everyday Health on MSN
7 tips for recovery after prostate cancer surgery
After a prostatectomy, you’ll need to consider factors like catheter management, sexual activity, and mental health. Here’s ...
A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results